Year: 1984
Type: article
Abstract: The Haslemere Group, Who Needs the Drug Companies?(1976).' Opren was suspended by the Licensing Authority on August 3, 1982, after more than 3,500 reports of adverse reactions, including 61 fatal cases, predominantly among elderly users.A number of negligence actions on behalf of English as well as American claimants are pending in the U.S.A., where there has already been one jury award of some f41 million: Sunday Times, December 4, 1983.Three other anti-arthritis drugs were withdrawn from the market in 1983: The Guardian, December 14,1983: Concern over Opren prompted introduction of the Medical Drugs (Manufacturers' Liability) Bill, a private member's Bill which sought to impose strict liability.It received its First Reading op December 14, 1982, but was not enacted.T. Mangold, "Relationships between doctors and salesmen are lurching out of control," The Listener, January 20, 1983.See also
Source: Modern Law Review
Author: Harvey Teff
Institution: Durham University
Language: English
Topic: Healthcare Regulation
Subfield: Health Information Management
Field: Health Professions
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2041539317